Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.59

-0.10 (-5.92%)

As of Jun 30, 10:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,087.4% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $1.59

Current
$1.59

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

1,602.5%

Low target

Base Case

$34.78

+2,087.4%

Avg target

Bull Case

$51.13

+3,115.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.39

-53.1% from high

52-Week Low

$0.16

+887.0% from low

Target vs 52W High

$34.78

+926.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%